Our products

Innovative Solutions for the early detection and management of cancer

Our products - Innovative Solutions for the early detection and management of cancer

Pacific Edge’s product benefits are compelling and seek to address a number of important current shortcomings in cancer detection and management, including the need for:

Earlier Detection

Pacific Edge is developing biomarker suites that characterise early stage cancer. Early diagnosis means treatment of cancer in its early stages, leading to improved characterisation, treatment and management.

Non-Invasive Testing

RNA and protein assays, like those developed by Pacific Edge, are performed on body fluids such as urine or blood and are thus minimally invasive and pain-free.

Greater Accuracy and Reliability

Pacific Edge is developing multiple biomarker assays with high sensitivity that are more reliable and objective than many other teststhat are currently available

Actionable Results

Pacific Edge is developing tests that provide actionable results in order to contribute a clinically meaningful difference in cancer treatment

Global Presence

We provide centralised diagnostic services through our own facilities in NZ and the US, and through licensed international partners

See where we are »

Patent Portfolio

Pacific Edge utilises experienced patent attorneys in both NZ and the US to support our intellectual property strategies

Our suite of intellectual property »